HDAC6-IN-5

Modify Date: 2025-09-05 19:00:16

HDAC6-IN-5 Structure
HDAC6-IN-5 structure
Common Name HDAC6-IN-5
CAS Number 2413603-15-1 Molecular Weight 408.25
Density N/A Boiling Point N/A
Molecular Formula C20H14BrN3O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HDAC6-IN-5


HDAC6-IN-5 (compound 11b) is a potent and BBB-penetrated HDAC6 inhibitor, with an IC50 of 0.025 μM. HDAC6-IN-5 exhibits strong inhibitory activity against Aβ1-42 self-aggregation and AChE, with IC50 values of 3.0 and 0.72 μM. HDAC6-IN-5 can enhance neurite outgrowth without significant neurotoxicity[1].

 Names

Name HDAC6-IN-5

 HDAC6-IN-5 Biological Activity

Description HDAC6-IN-5 (compound 11b) is a potent and BBB-penetrated HDAC6 inhibitor, with an IC50 of 0.025 μM. HDAC6-IN-5 exhibits strong inhibitory activity against Aβ1-42 self-aggregation and AChE, with IC50 values of 3.0 and 0.72 μM. HDAC6-IN-5 can enhance neurite outgrowth without significant neurotoxicity[1].
Related Catalog
Target

HDAC6:0.026 ± 0. μM (IC50)

HDAC1:0.09 ± 0.0 μM (IC50)

HDAC:0.16 ± 0.0 μM (IC50)

HDAC3:0.33 ± 0. μM (IC50)

HDAC2:0.48 ± 0.0 μM (IC50)

HDAC9:5.51 ± 0.0 μM (IC50)

HDAC5:7.19 ± 0.4 μM (IC50)

HDAC4:7.85 ± 0.6 μM (IC50)

HDAC7:9.13 ± 0.3 μM (IC50)

In Vitro HDAC6-IN-5 (compound 11b) induces histone H3 and α-tubulin acetylation in a dose-dependent manner, with EC50 values of 0.58 and 8 μM, respectively[1]
References

[1]. Tseng HJ, et al. Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease. Eur J Med Chem. 2020 Apr 15;192:112193.

 Chemical & Physical Properties

Molecular Formula C20H14BrN3O2
Molecular Weight 408.25
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.